West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 151,200 | 346,200 | 247,800 | 165,500 | 74,300 |
| Depreciation Amortization | 29,100 | 109,100 | 80,600 | 52,200 | 26,000 |
| Income taxes - deferred | N/A | -5,800 | N/A | N/A | N/A |
| Accounts receivable | N/A | -46,600 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 36,600 | N/A | N/A | N/A |
| Other Working Capital | -94,900 | -10,300 | -34,900 | -27,300 | -45,600 |
| Other Operating Activity | 3,300 | 43,300 | 30,300 | 14,800 | 2,400 |
| Operating Cash Flow | $88,700 | $472,500 | $323,800 | $205,200 | $57,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54,700 | -174,400 | -116,700 | -69,200 | -32,100 |
| Purchase Sale Intangibles | N/A | N/A | -3,800 | -3,800 | N/A |
| Other Investing Activity | 200 | -5,100 | -5,200 | -3,600 | 200 |
| Investing Cash Flow | $-54,500 | $-179,500 | $-121,900 | $-72,800 | $-31,900 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -600 | -2,300 | -1,700 | -1,100 | -600 |
| Common Stock Issued | 7,600 | 34,700 | 26,600 | 21,300 | 8,800 |
| Common Stock Repurchased | -150,800 | -121,400 | -117,800 | -117,800 | -116,700 |
| Dividend Paid | -12,600 | -48,100 | -35,500 | -23,600 | -11,800 |
| Financing Cash Flow | $-156,400 | $-137,100 | $-128,400 | $-121,200 | $-120,300 |
| Exchange Rate Effect | -9,600 | 20,500 | 6,800 | -4,400 | -8,700 |
| Beginning Cash Position | 615,500 | 439,100 | 439,100 | 439,100 | 439,100 |
| End Cash Position | 483,700 | 615,500 | 519,400 | 445,900 | 335,300 |
| Net Cash Flow | $-131,800 | $176,400 | $80,300 | $6,800 | $-103,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 88,700 | 472,500 | 323,800 | 205,200 | 57,100 |
| Capital Expenditure | -54,700 | -174,400 | -116,700 | -69,200 | -32,100 |
| Free Cash Flow | 34,000 | 298,100 | 207,100 | 136,000 | 25,000 |